Cellarity, Flagship's $50M bet on Network Biology, Marries Machine Learning and Single-Cell Tech for Drug Discovery

Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases